Mohammad Ali Khalili

ORCID: 0000-0001-9940-749X · 7 papers in corpus
rct 2025
Reproductive medicine and biology ·doi:10.1002/rmb2.70000

PURPOSE: The selection of high-quality spermatozoa affects embryo quality and, consequently, the success rates of clinical outcomes. This study aimed to evaluate the efficacy of a cumulus cell-based sperm selection method for identifying hi…

other 2022
Turkish journal of obstetrics and gynecology ·doi:10.4274/tjod.galenos.2022.42272

Due to the increase in cancer among young women, the risk of premature ovarian insufficiency with subsequent infertility has been raised. Fertility preservation restores reproductive potential along with increasing life expectancy in these …

other 2022
Clinical and experimental reproductive medicine ·doi:10.5653/cerm.2021.05050

OBJECTIVE: Optimizing culture media for the incubation of immature oocytes is a vital strategy to increase the oocyte maturation rate during in vitro maturation (IVM) programs. This study evaluated the IVM and fertilization rates of human g…

observational 2020
Journal of reproduction & infertility

BACKGROUND: The aim of this study was to assess the impact of total serum E2 on the day of human chronic gonadotropin (hCG) administration and the serum E2 per oocyte ratio on the outcomes of assisted reproductive technology (ART) cycles. …

other 2019
Clinical and experimental reproductive medicine ·doi:10.5653/cerm.2019.00402

OBJECTIVE: In vitro maturation (IVM) of immature oocytes can be useful for some infertile patients. In IVM programs, the rates of embryo formation and pregnancy are low. Therefore, it is essential to recognize the main factors involved in r…

case-report 2016
Clinical and experimental reproductive medicine ·doi:10.5653/cerm.2016.43.3.181

The aim was to report a healthy live birth using re-vitrified-warmed cleavage-stage embryos derived from supernumerary warmed embryos after frozen embryo transfer (ET) in a patient with recurrent implantation failure (RIF). The case was a 3…

other 2012
Iranian journal of reproductive medicine

BACKGROUND: Human chorionic gonadotropin (HCG) has been used as a replacement for the mid-cycle luteinizing hormone (LH) surge for several years. The recent arrival of recombinant DNA technology has made recombinant HCG (rHCG) accessible. …